Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Melanoma vaccine shows promise; approved for phase 3 trial
